ML
Malin Corporation plc
MLC.IR · DUB
7.00 € +0.00% (+0.00 €)
1M +0.00%
Market Cap 31.1M €
P/E Ratio -
Div. Yield -
ROE 0.00%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
29 /100
Expensive EV/EBITDA 60.96x
P/B 0.81x
P/E N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
1 /100
Poor ROIC 6.07%
Asset turnover 0.00x
ROE 0.00%
Debt
82 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -43.09x
Current ratio 16.13x
Stability
56 /100
Moderate Beta 0.42x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MLC.IR
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Fiona Dunlevy
Employees
2
Headquarters
Dublin